Tennessee cardiovascular health program - tennessee department of health (TDH), 710 james robertson parkway, nashville, TN 37243, is applying for CDC-RFA-DP-23-0004, the national cardiovascular health…

Tennessee cardiovascular health program - tennessee department of health (TDH), 710 james robertson parkway, nashville, TN 37243, is applying for CDC-RFA-DP-23-0004, the national cardiovascular health program. TDH has the capability to serve all populations and communities statewide and identified priority counties. Six in 10 americans live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the united states (US), and the leading drivers of healthcare costs. According to america's health rankings (2022), tennessee (TN) ranks 44TH for overall health. The annual report showed TN ranked in the bottom 10 states for multiple factors and indicated considerable challenges affecting the health and well-being of tennesseans, including diabetes (46TH), cardiovascular disease (CVD; 46TH), hypertension (HTN; 41ST), multiple chronic conditions (46TH), food insecurity (35TH), physical inactivity (43RD), youth overweight and obesity (41ST), and adult obesity (31ST). Atherosclerotic cardiovascular disease (CVD) refers to four conditions: coronary artery disease (CAD) which is also referred to as coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease (pad), and aortic atherosclerosis (including thoracic and abdominal aneurysms). According to TN statewide leading cause of death data (2020; all races), heart disease remains the leading cause of death followed by cerebrovascular disease (6TH) and HTN and renal disease (13TH) for tennesseans. As shown on the CDC interactive atlas of heart disease and stroke (2018-2020), 22 of TN's 95 counties, have the highest total cardiovascular burden and related risk factors. Emphasis on CVD awareness and education will focus on the following counties: lake, obion, dyer, henry, lauderdale, crockett, gibson, carroll, humphrey, decatur, perry, mcnairy, hardin, lawrence, giles, marshall, bedford, lincoln, grundy, campbell, claiborne, and cocke. These counties are vulnerable to CVD due to risk factors such as increased rates of HTN and hyperlipidemia, ranking high on the social vulnerability index (SVI), and being distressed due to their low population density and lack of access to resources. This funding opportunity will build on the accomplishments and outcomes achieved in the healthcare system and community-clinical link domains of the DP18-1815 and allow TDH to work deliberately on systems change and advancement of health equity. The provisions awarded will support the prioritization of populations and communities with the highest prevalence and those disproportionately affected by CVD, specifically HTN, high cholesterol, and stroke through partnerships with heart disease and stroke learning collaboratives (LC) and other innovative initiatives to support the following strategies: - strategy 1: track and monitor clinical and social services and support needs measures shown to improve health and wellness, health care quality, and identify patients at the highest risk of CVD with a focus on HTN and high cholesterol. - strategy 2: implement team-based care to prevent and reduce CVD risk with a focus on HTN and high cholesterol prevention, detection, control, and management through mitigation of social support barriers to improve outcomes. - strategy 3: link community resources and clinical services that support bidirectional referrals, self-management, and lifestyle change to address social determinants that put priority populations at increased risk of cardiovascular disease. Within five years TN will demonstrate: - improved blood pressure control among populations within partner health care and community settings. - reduced disparities in hypertension control among populations within partner health care and community settings. - increased utilization of social services and support among populations at the highest risk of CVD, with a focus on hypertension and high cholesterol.